ReviewEuropean journal of nuclear medicine and molecular imaging2021

HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging.

Betül Altunay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.